Chugai Pharmaceutical Co., Ltd. (CHGCY)
OTCMKTS · Delayed Price · Currency is USD
22.27
+0.08 (0.34%)
Sep 5, 2025, 3:55 PM EDT

Chugai Pharmaceutical Statistics

Total Valuation

CHGCY has a market cap or net worth of 74.07 billion. The enterprise value is 67.08 billion.

Market Cap74.07B
Enterprise Value 67.08B

Important Dates

The next estimated earnings date is Friday, October 24, 2025.

Earnings Date Oct 24, 2025
Ex-Dividend Date Dec 29, 2025

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) +0.01%
Shares Change (QoQ) -0.01%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 639.77M

Valuation Ratios

The trailing PE ratio is 27.02.

PE Ratio 27.02
Forward PE n/a
PS Ratio 8.93
PB Ratio 5.38
P/TBV Ratio 5.47
P/FCF Ratio 27.01
P/OCF Ratio 23.12
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.74, with an EV/FCF ratio of 24.46.

EV / Earnings 24.47
EV / Sales 8.24
EV / EBITDA 16.74
EV / EBIT 17.69
EV / FCF 24.46

Financial Position

The company has a current ratio of 6.04

Current Ratio 6.04
Quick Ratio 5.01
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage 10,512.24

Financial Efficiency

Return on equity (ROE) is 21.16% and return on invested capital (ROIC) is 18.64%.

Return on Equity (ROE) 21.16%
Return on Assets (ROA) 16.05%
Return on Invested Capital (ROIC) 18.64%
Return on Capital Employed (ROCE) 27.72%
Revenue Per Employee 1.65M
Profits Per Employee 545,341
Employee Count5,026
Asset Turnover 0.55
Inventory Turnover 1.41

Taxes

In the past 12 months, CHGCY has paid 1.11 billion in taxes.

Income Tax 1.11B
Effective Tax Rate 28.90%

Stock Price Statistics

The stock price has decreased by -6.84% in the last 52 weeks. The beta is 0.69, so CHGCY's price volatility has been lower than the market average.

Beta (5Y) 0.69
52-Week Price Change -6.84%
50-Day Moving Average 23.04
200-Day Moving Average 23.71
Relative Strength Index (RSI) 50.71
Average Volume (20 Days) 242,330

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, CHGCY had revenue of 8.29 billion and earned 2.74 billion in profits. Earnings per share was 1.67.

Revenue8.29B
Gross Profit 5.83B
Operating Income 3.86B
Pretax Income 3.85B
Net Income 2.74B
EBITDA 4.08B
EBIT 3.86B
Earnings Per Share (EPS) 1.67
Full Income Statement

Balance Sheet

The company has 7.12 billion in cash and n/a in debt, giving a net cash position of 7.12 billion.

Cash & Cash Equivalents 7.12B
Total Debt n/a
Net Cash 7.12B
Net Cash Per Share n/a
Equity (Book Value) 13.76B
Book Value Per Share 8.36
Working Capital 9.37B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 3.20 billion and capital expenditures -460.71 million, giving a free cash flow of 2.74 billion.

Operating Cash Flow 3.20B
Capital Expenditures -460.71M
Free Cash Flow 2.74B
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 70.37%, with operating and profit margins of 46.58% and 33.06%.

Gross Margin 70.37%
Operating Margin 46.58%
Pretax Margin 46.49%
Profit Margin 33.06%
EBITDA Margin 49.22%
EBIT Margin 46.58%
FCF Margin 33.08%

Dividends & Yields

This stock pays an annual dividend of 1.71, which amounts to a dividend yield of 7.70%.

Dividend Per Share 1.71
Dividend Yield 7.70%
Dividend Growth (YoY) 177.71%
Years of Dividend Growth 1
Payout Ratio 40.86%
Buyback Yield -0.01%
Shareholder Yield 7.69%
Earnings Yield 3.70%
FCF Yield 3.70%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on July 6, 2020. It was a forward split with a ratio of 12.

Last Split Date Jul 6, 2020
Split Type Forward
Split Ratio 12

Scores

CHGCY has an Altman Z-Score of 26.68 and a Piotroski F-Score of 6.

Altman Z-Score 26.68
Piotroski F-Score 6